# Protection From Cisplatin Ototoxicity by Lactated Ringers

> **NCT00584155** · PHASE1 · WITHDRAWN · sponsor: **University of Oklahoma**

## Conditions studied

- Hearing Loss

## Interventions

- **DRUG:** Normal Saline and 0.3% ofloxacin
- **DRUG:** Lactated Ringer's with 0.03% Ofloxacin

## Key facts

- **NCT ID:** NCT00584155
- **Lead sponsor:** University of Oklahoma
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2006-07
- **Primary completion:** 2010-06
- **Final completion:** 2010-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** PI left the university.
- **Last updated:** 2015-05-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00584155

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00584155, "Protection From Cisplatin Ototoxicity by Lactated Ringers". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00584155. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*